Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis
- PMID: 10589360
Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis
Abstract
An open-label, one-year study was conducted to evaluate the safety and clinical response to leflunomide and methotrexate combination therapy for rheumatoid arthritis. Study results revealed tolerable safety, no significant pharmacokinetic interactions between methotrexate and leflunomide, and suggested improved clinical response with combination therapy.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical